Wegovy is indicated for reducing the risk of major cardiovascular events in adults who are overweight or have known cardiovascular diseases such as hypertension
GLP-1RAs have been proven to reduce the risk of major adverse cardiovascular events (MACE) occurrence, including death from cardiovascular causes, non-fatal myocardial infarction and non-fatal stroke, as well as all-cause mortality in T2DM and patients with obesity ( The glucocorticoid receptors are present in GLP-1-producing cells, and their activation diminishes the secretory responsiveness of these cells ( 4.1 Efficacy of GLP-1 receptor agonist therapy in SID Considering their beneficial effects on body weight, effective glycemic control, and low risk of hypoglycaemia, GLP-1 RAs may be suitable therapeutic options for SID and SIH, either as adjunctive therapy or as primary treatment
The cardiovascular effects of retatrutide are multidimensional, and several of them are strongly protective
Its program leans on medication management rather than coaching, with mental-health evaluation built into the process
Good VIBES Researchers at the Massachusetts Institute of Technology, in Cambridge, have taken a different approach to reducing our urge to overeat